Literature DB >> 16362364

Increased density of GABAA receptors in the superior temporal gyrus in schizophrenia.

Chao Deng1, Xu-Feng Huang.   

Abstract

The superior temporal gyrus (STG) is strongly implicated in the pathophysiology of schizophrenia, particularly with regards to auditory hallucinations. In a previous study we reported a decrease in the density of M1 and M2/M4 muscarinic receptors in the STG in schizophrenia. In this study, we investigated the density of GABA(A) receptors in the left STG of schizophrenia patients compared to control subjects. We used quantitative autoradiography to investigate the binding of the agonist [(3)H] muscimol to GABA(A )receptors in the STG. A significantly higher density of [(3)H] muscimol binding was observed in the upper three quarters of the STG grey matter (corresponding to layers I-IV) than in the lower one-quarter (layers V-VI) in both groups. A significant increase (about 30%, P<0.05) in binding of [(3)H] muscimol was clearly observed in schizophrenia patients compared to control subjects. There were no significant correlations between [(3)H] muscimol binding density and age, post-mortem interval, brain pH or final recorded antipsychotic drug use. These results suggest an increase of GABA(A) receptor densities in the STG of schizophrenia patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362364     DOI: 10.1007/s00221-005-0290-9

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  28 in total

Review 1.  GABA(A) receptor subtypes: dissecting their pharmacological functions.

Authors:  U Rudolph; F Crestani; H Möhler
Journal:  Trends Pharmacol Sci       Date:  2001-04       Impact factor: 14.819

2.  Benzodiazepine receptors in the post-mortem brain of suicide victims and schizophrenic subjects.

Authors:  G N Pandey; R R Conley; S C Pandey; S Goel; R C Roberts; C A Tamminga; D Chute; J Smialek
Journal:  Psychiatry Res       Date:  1997-08-08       Impact factor: 3.222

3.  Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects.

Authors:  F M Benes; S L Vincent; A Marie; Y Khan
Journal:  Neuroscience       Date:  1996-12       Impact factor: 3.590

4.  Decreased density of muscarinic receptors in the superior temporal gyrusin schizophrenia.

Authors:  Chao Deng; Xu-Feng Huang
Journal:  J Neurosci Res       Date:  2005-09-15       Impact factor: 4.164

Review 5.  Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory.

Authors:  E A van der Zee; P G Luiten
Journal:  Prog Neurobiol       Date:  1999-08       Impact factor: 11.685

6.  On high- and low-affinity agonist sites in GABAA receptors.

Authors:  Roland Baur; Erwin Sigel
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

7.  A functional neuroanatomy of hallucinations in schizophrenia.

Authors:  D A Silbersweig; E Stern; C Frith; C Cahill; A Holmes; S Grootoonk; J Seaward; P McKenna; S E Chua; L Schnorr
Journal:  Nature       Date:  1995-11-09       Impact factor: 49.962

8.  Kraepelin revisited: a reassessment and statistical analysis of dementia praecox and manic-depressive insanity in 1908.

Authors:  A Jablensky; H Hugler; M Von Cranach; K Kalinov
Journal:  Psychol Med       Date:  1993-11       Impact factor: 7.723

9.  Muscarinic M1 receptor mediated inhibition of GABA release from rat cerebral cortex.

Authors:  T Hashimoto; H Shu; K Kuriyama
Journal:  Neurochem Int       Date:  1994-04       Impact factor: 3.921

Review 10.  GABA and schizophrenia: a review of basic science and clinical studies.

Authors:  Adel Wassef; Jeffrey Baker; Lisa D Kochan
Journal:  J Clin Psychopharmacol       Date:  2003-12       Impact factor: 3.153

View more
  26 in total

Review 1.  Multifunctional pharmacotherapy: what can we learn from study of selective serotonin reuptake inhibitor augmentation of antipsychotics in negative-symptom schizophrenia?

Authors:  Henry Silver; Yael Chertkow; Orly Weinreb; Lena Danovich; Moussa Youdim
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

Review 2.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

3.  Preliminary evidence for reduced auditory lateral suppression in schizophrenia.

Authors:  Erin M Ramage; David M Weintraub; Sally J Vogel; Griffin P Sutton; Erik N Ringdahl; Daniel N Allen; Joel S Snyder
Journal:  Schizophr Res       Date:  2015-01-10       Impact factor: 4.939

4.  Characterization of Glutamatergic and GABAA-Mediated Neurotransmission in Motor and Dorsolateral Prefrontal Cortex Using Paired-Pulse TMS-EEG.

Authors:  Robin F H Cash; Yoshihiro Noda; Reza Zomorrodi; Natasha Radhu; Faranak Farzan; Tarek K Rajji; Paul B Fitzgerald; Robert Chen; Zafiris J Daskalakis; Daniel M Blumberger
Journal:  Neuropsychopharmacology       Date:  2016-07-27       Impact factor: 7.853

5.  Converging evidence for gamma synchrony deficits in schizophrenia.

Authors:  B J Roach; J M Ford; R E Hoffman; D H Mathalon
Journal:  Suppl Clin Neurophysiol       Date:  2013

6.  Aripiprazole Increases the PKA Signalling and Expression of the GABAA Receptor and CREB1 in the Nucleus Accumbens of Rats.

Authors:  Bo Pan; Jiamei Lian; Xu-Feng Huang; Chao Deng
Journal:  J Mol Neurosci       Date:  2016-02-19       Impact factor: 3.444

Review 7.  Neuregulin-1 signalling and antipsychotic treatment: potential therapeutic targets in a schizophrenia candidate signalling pathway.

Authors:  Chao Deng; Bo Pan; Martin Engel; Xu-Feng Huang
Journal:  Psychopharmacology (Berl)       Date:  2013-02-07       Impact factor: 4.530

8.  GABAergic modulation of the 40 Hz auditory steady-state response in a rat model of schizophrenia.

Authors:  Jenifer L Vohs; R Andrew Chambers; Giri P Krishnan; Brian F O'Donnell; Sarah Berg; Sandra L Morzorati
Journal:  Int J Neuropsychopharmacol       Date:  2009-07-23       Impact factor: 5.176

Review 9.  Molecular mechanisms underlying synergistic effects of SSRI-antipsychotic augmentation in treatment of negative symptoms in schizophrenia.

Authors:  Yael Chertkow; Orly Weinreb; Moussa B H Youdim; Henry Silver
Journal:  J Neural Transm (Vienna)       Date:  2009-07-04       Impact factor: 3.575

10.  N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia.

Authors:  Toni Marie Mueller; Vahram Haroutunian; James H Meador-Woodruff
Journal:  Neuropsychopharmacology       Date:  2013-08-06       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.